Cancer‐associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline
Raza Alikhan,Keith Gomez,Anthony Maraveyas,Simon Noble,Annie Young,Mari Thomas,the British Society for Haematology
DOI: https://doi.org/10.1111/bjh.19414
2024-04-27
British Journal of Haematology
Abstract:A shared decision on the most appropriate agent for the treatment of cancer‐associated thrombosis should consider the following factors, which should be reassessed as patients continue along their cancer care pathway: risk of bleeding; tumour site; suitability of oral medications; potential for drug–drug interactions; and patient preference and values regarding choice of drug. Continuing anticoagulation beyond 6 months in patients with cancer‐associated venous thromboembolism and active cancer is recommended.
hematology
What problem does this paper attempt to address?